Dulera

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
Phase 3
5
Approved
Indication / Disease

Asthma

Conditions

Asthma

Trial Timeline

Mar 4, 2014 → Jul 12, 2017

About Dulera

Dulera is a approved stage product being developed by Merck for Asthma. The current trial status is completed. This product is registered under clinical trial identifier NCT02045875. Target conditions include Asthma.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT02045875ApprovedCompleted